Boiron S.A.
PAR: BOI.PA0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Euronext Paris
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Thierry Boiron
- Employees
- 2,469
- Headquarters
- Messimy, France
- IPO year
- 1991
- Market cap
- €477.5M
- Website
- https://www.boiron.fr
Loading BOI…
Loading profile data…Frequently asked questions about BOI
What does Boiron S.A. (BOI.PA) do?
Boiron SA manufactures and sells homeopathic medicines in France, rest of Europe, North America, and internationally. The company offers non-proprietary, proprietary, branded homeopathic medicines. Its branded homeopathic medicines include Oscillococcinum to treat influenza symptoms, such as fever, chills, headaches, and aches; Stodal and Stodal...
Where does BOI.PA trade?
Boiron S.A. (BOI.PA) trades on the Euronext Paris.
What sector is BOI.PA in?
Boiron S.A. (BOI.PA) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Boiron S.A.?
Thierry Boiron is the chief executive officer of Boiron S.A. (BOI.PA).
Where is Boiron S.A. headquartered?
Boiron S.A. is headquartered in France.
Does BOI.PA pay a dividend?
Yes — Boiron S.A. (BOI.PA) paid a trailing twelve-month dividend of EUR 1.20 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did BOI.PA go public?
Boiron S.A. (BOI.PA) completed its initial public offering in 1991.